Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine
- DOI
- 10.1016/j.ejca.2017.07.026
- Published
- 2017-10
- Container
- European Journal of Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2017.07.026,
title = {Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine},
author = {Laetitia Nebot-Bral and David Brandao and Loic Verlingue and Etienne Rouleau and Olivier Caron and Emmanuelle Despras and Yolla El-Dakdouki and Stéphane Champiat and Said Aoufouchi and Alexandra Leary and Aurélien Marabelle and David Malka and Nathalie Chaput and Patricia L. Kannouche},
year = {2017},
journal = {European Journal of Cancer},
doi = {10.1016/j.ejca.2017.07.026},
url = {https://doi.org/10.1016/j.ejca.2017.07.026}
}RIS
TY - JOUR TI - Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine AU - Laetitia Nebot-Bral AU - David Brandao AU - Loic Verlingue AU - Etienne Rouleau AU - Olivier Caron AU - Emmanuelle Despras AU - Yolla El-Dakdouki AU - Stéphane Champiat AU - Said Aoufouchi AU - Alexandra Leary AU - Aurélien Marabelle AU - David Malka AU - Nathalie Chaput AU - Patricia L. Kannouche PY - 2017 JO - European Journal of Cancer DO - 10.1016/j.ejca.2017.07.026 UR - https://doi.org/10.1016/j.ejca.2017.07.026 ER -
APA
Nebot-Bral, L., Brandao, D., Verlingue, L., Rouleau, E., Caron, O., Despras, E., El-Dakdouki, Y., Champiat, S., Aoufouchi, S., Leary, A., Marabelle, A., Malka, D., Chaput, N., & Kannouche, P. L. (2017). Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2017.07.026
Source records
- crossref · retrieved 2026-09-25T07:55:54.751Z